English
简体中文
Total: £ 56.28
2025-04-24 | Pages: 71 | Tables: 72
The global market for Elapegademase-lvlr was valued at US$ 16.1 million in the year 2024 and is projected to reach a revised size of US$ 20.5 million by 2031, growing at a CAGR of 3.6% during the forecast period.Revcovi (elapegademase-lvlr) is a new ...
2025-04-24 | Pages: 83 | Tables: 85
The global market for Onychomycosis (Tinea Unguium) Drug was valued at US$ 3677 million in the year 2024 and is projected to reach a revised size of US$ 5427 million by 2031, growing at a CAGR of 5.8% during the forecast period.Onychomycosis is a fun...
2025-04-24 | Pages: 70 | Tables: 75
The global market for Nerve Repair and Re-generation was valued at US$ 672 million in the year 2024 and is projected to reach a revised size of US$ 3320 million by 2031, growing at a CAGR of 26.0% during the forecast period.Nerve damages can be cause...
2025-04-24 | Pages: 67 | Tables: 72
The global market for Insulin Lispro was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.Insulin lispro is synthetic insulin with a very rapid on...
2025-04-24 | Pages: 78 | Tables: 82
The global market for HPMC Capsules was valued at US$ 652 million in the year 2024 and is projected to reach a revised size of US$ 1080 million by 2031, growing at a CAGR of 7.6% during the forecast period.HPMC Capsules are two-piece capsules made fr...
2025-04-24 | Pages: 73 | Tables: 77
The global market for Gaucher Disease was valued at US$ 1426 million in the year 2024 and is projected to reach a revised size of US$ 2536 million by 2031, growing at a CAGR of 8.7% during the forecast period.Gaucher disease is an inherited disorder ...
2025-04-24 | Pages: 79 | Tables: 78
The global market for Liver Fibrosis Drug was valued at US$ 11540 million in the year 2024 and is projected to reach a revised size of US$ 10250 million by 2031, growing at a CAGR of -1.7% during the forecast period.Liver fibrosis is the scarring pro...
2025-04-24 | Pages: 88 | Tables: 96
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.Global key players of crude heparin include...
2025-04-24 | Pages: 78 | Tables: 79
The global Ibuprofen market size was US$ 98 million in 2024 and is forecast to a readjusted size of US$ 118 million by 2031 with a CAGR of 2.7% during the forecast period 2025-2031. Ibuprofen is an API which is used to produce ibuprofen drugs. Finish...
2025-04-24 | Pages: 91 | Tables: 96
The global Human Growth Hormone market size was US$ 4761 million in 2024 and is forecast to a readjusted size of US$ 5997 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031. Growth hormone (GH), also known as somatotropin (or as...
2025-04-24 | Pages: 77 | Tables: 80
The global Follicle Stimulating Hormone market size was US$ 1347 million in 2024 and is forecast to a readjusted size of US$ 1630 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031. Follicle stimulating hormone (FSH) is a hormon...
2025-04-24 | Pages: 94 | Tables: 93
The global Bio Pharma Buffer market size was US$ 966 million in 2024 and is forecast to a readjusted size of US$ 1561 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031. A buffer solution is comprised of a weak conjugate acid-ba...
2025-04-24 | Pages: 105 | Tables: 103
The global Vitamin D Testing market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Vitamin D is vital for strong bones. It also has important, emerging ro...
2025-04-24 | Pages: 76 | Tables: 76
The global Targeted RNA Sequencing market size was US$ 2694 million in 2024 and is forecast to a readjusted size of US$ 10950 million by 2031 with a CAGR of 22.5% during the forecast period 2025-2031. Targeted RNA-sequencing (RNA-Seq) is a highly acc...
2025-04-24 | Pages: 80 | Tables: 77
The global Milk Allergy Clinical Trials Review market size was US$ 1081 million in 2024 and is forecast to a readjusted size of US$ 1308 million by 2031 with a CAGR of 2.8% during the forecast period 2025-2031. Cow’s milk allergy (CMA) is among the m...
